# Safety and Efficacy of MTS Versus Concerta in Pediatric Patients (Aged 6-12 Years) With ADHD

> **NCT00444574** · PHASE3 · COMPLETED · sponsor: **Noven Therapeutics** · enrollment: 282 (actual)

## Conditions studied

- Attention Deficit Hyperactivity Disorder

## Interventions

- **DRUG:** Methylphenidate Transdermal System
- **DRUG:** Placebo
- **DRUG:** Concerta

## Key facts

- **NCT ID:** NCT00444574
- **Lead sponsor:** Noven Therapeutics
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2004-09
- **Primary completion:** 2005-06
- **Final completion:** 2005-06
- **Target enrollment:** 282 (ACTUAL)
- **Last updated:** 2015-06-25


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00444574

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00444574, "Safety and Efficacy of MTS Versus Concerta in Pediatric Patients (Aged 6-12 Years) With ADHD". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT00444574. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*